The Food and Drug Administration agreed to begin a review of biotech company Moderna’s application to <a href="https://www.wsj.com/health/healthcare/fda-reverses-course-and-will-now-review-modernas-flu-shot-46b3aab1?mod=WSJ_TJPOD">make a new seasonal flu shot available</a>. The decision comes after the FDA initially refused to review the company's application. It's a back and forth that reveals increased turmoil within the agency. WSJ’s <a href="https://www.wsj.com/news/author/liz-essley-whyte?mod=WSJ_TJPOD">Liz Essley Whyte</a> takes us inside the FDA’s unexpected reversals and explores what’s next for the mRNA flu vaccine. <a href="https://www.wsj.com/news/author/jessica-mendoza?mod=WSJ_TJPOD">Jessica Mendoza</a> hosts. 

Further Listening: 
- <a href="https://open.spotify.com/episode/6MagZYmn2H7w2Y5dxOs3F2?si=e3b0959e9d324d4e">The FDA Commissioner on Vaccines and Public Trust</a>
- <a href="https://open.spotify.com/episode/43rSCVetkuExIvMeZkNVrF?si=a3cd2f1ed2ce4b3d">Breakfast Battle: The Cereal Industry vs MAHA</a>

Sign up for WSJ’s free <a href="https://www.wsj.com/newsletters/whats-news?mod=WSJ_TJPOD">What’s News newsletter</a>.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

The Flu Shot Drama at the FDA

The Journal.

AI Chapters

AI Insights

Reviews